Biotech startup NiKang raises $200M
June 9, 2021
WILMINGTON – NiKang Therapeutics, a clinical stage biotech startup focused on small molecule cancer treatments, recently closed a $200 million Series C financing round, one of the largest such venture […]
chat_bubble0 Comment
visibility1354 Views
Premier Digital Partners
© 2023 Delaware Business Times
